GlassScriptPhysician profile
Gowri Gowda
NPI 1881388536
$2,663.62
in general payments reported to CMS, 2019-2025
8 companies · $1,377 in 2025
The $1,377 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,287 · 2025: $1,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415 · Grant: $1,000 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.81 |
| Grant | $1,000.00 |
| Education | $248.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,711.45 | 2024-2025 | Endurant Iis, In.Pact Admiral, Valiant Captivia |
| Penumbra, INC. | $303.03 | 2025 | Ruby Coil |
| Stryker Corporation | $162.77 | 2025 | Artix Mt, Venacore Thrombectomy Catheter |
| Shockwave Medical, INC | $143.45 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $137.18 | 2025 | Alto Abdominal Stent Graft System |
| Abbvie INC. | $80.87 | 2024 | |
| Boston Scientific Corporation | $67.83 | 2024 | Eluvia, Ekosonic |
| Terumo Medical Corporation | $57.04 | 2024 | Glidesheath Slender, Tr Band, Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gowri Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.